Altered levels of serum haptoglobin and apo A-I in schizophrenia

QR Code

Altered levels of serum haptoglobin and apo A-I in schizophrenia

Schizophrenia is a debilitating psychiatric syndrome that affects 1% of the world’s population. Abnormalities in immune functions and role of inflammatory markers have been widely described in schizophrenia. With the alarming high prevalence, this study aims to investigate the association of acute p...

Full description

Bibliographic Details
Main Authors:	Tze Jen Chow, Han Chern Loh
Format:	Article
Language:	English
Published:	Universiti Kebangsaan Malaysia 2011
Online Access:	http://journalarticle.ukm.my/2946/ http://journalarticle.ukm.my/2946/1/18_Tze_Jen_Chow.pdf

Similar Items

Identification of chemical and biological markers for schizophrenia
by: Chow, Tze Jen
Published: (2011)

Responses of haptoglobin and serum amyloid A in goats inoculated intradermally with C. pseudotuberculosis and mycolic acid extract immunogen
by: Ahmed Odhah, Mohammed Naji, et al.
Published: (2018)

Targeted Next Generation Sequencing of ZNF804A, DTNBP1, AKT1 AND TCF4 to Identify Risk Variants in Schizophrenia Multiplex Families
by: Chow , Tze Jen
Published: (2018)

Modifications in serum Amyloid A and Haptoglobin in mice following oral inoculation of graded doses of P. multocida type B: 2 and its lipopolysaccharide
by: Abdullah, Faez Firdaus Jesse, et al.
Published: (2014)

Impact of systemic inflammation and autoimmune diseases on apoA-i and HDL plasma levels and functions
by: Montecucco, F., et al.
Published: (2015)

Plasma haptoglobin as a potential biomarker for coronary artery disease in young hypertensive adults
by: Norbaiyah, Mohamed Bakrim, et al.
Published: (2024)

Structural alterations of the social brain: A comparison between schizophrenia and autism
by: Radeloff, D., et al.
Published: (2014)

Carotenoid as a potential antioxidant marker for schizophrenia
by: Chow, T.J, et al.
Published: (2012)

APOE-E4 and APOE-491A polymorphisms in individuals with subjective memory loss
by: Laws, S., et al.
Published: (2002)

Identification of haptoglobin as a potential biomarker in young adults with acute myocardial infarction by proteomic analysis
by: Mohamed Bakrim, Norbaiyah, et al.
Published: (2020)

DNA methylation analysis of AKT1 promoter and HTR2A exon-I of Malaysian schizophrenia multiplex families with lower cognitive performance
by: Erna Laere,, et al.
Published: (2020)

The immuno localisation of aplipoproteins B-48 (APO B-48) and B-100 (APO B-100) in human tissues
by: Mohd Esa, Norhaizan, et al.
Published: (2001)

Investigating ApoE4-Mediated Molecular Alterations in H4 Neuroglioma Cells of Alzheimer’s Disease Using OrbiSIMS and LC-MS/MS.
by: Lu, Li
Published: (2025)

Intimal retention cholesterol derived from apoB48 and apoB100-containing lipoproteins in carotid arteries from WHHL rabbits.
by: Proctor, Spencer, et al.
Published: (2003)

Alleles of apolipoprotein E gene (APOE) as genetic determinants of dementia
by: Akter, Seikh Farid Uddin, et al.
Published: (2012)

Evaluation of maternal immune activation with post-weaning social isolation as a potential rat model for schizophrenia
by: Goh, Jen-Yin
Published: (2020)

Characterization of behavioral, signaling and cytokine alterations in a rat neurodevelopmental model for schizophrenia, and their reversal by the 5-HT₆ receptor antagonist SB-399885
by: Shortall, Sinead E., et al.
Published: (2018)

Managing ‘schizophrenia in the midst of schizophrenia’- the role of assertive community treatment
by: Md Rosli, Ahmad Nabil, et al.
Published: (2014)

Managing ‘Schizophrenia in the Midst of Schizophrenia’- the role of assertive community treatment.
by: Ahmad Nabil MR,, et al.
Published: (2014)

Alterations of cholesterol lowering-related proteins in the serum of hypercholesterolemic-induced rats treated with Ficus deltoidea
by: Chuo, Peck Ham, et al.
Published: (2020)

LOW DOSE DIETARY NITRATE IMPROVES ENDOTHELIAL DYSFUNCTION IN THE APOE(-/-) MOUSE
by: Bakker, J., et al.
Published: (2016)

Disrupted-in-schizophrenia-1 SNPs and susceptibility to schizophrenia: evidence from Malaysia
by: A. Talib, Norlelawati, et al.
Published: (2015)

Gallstone, snake venom and witchcraft for schizophrenia: the challenges of classifying [schizophrenia] trials
by: Shokraneh, Farhad, et al.
Published: (2018)

Reviewing the epigenetics of schizophrenia
by: Cromby, John, et al.
Published: (2016)

Trichotillomania Comorbid with Schizophrenia
by: Othman, Zahiruddin, et al.
Published: (2019)

Clozapine dose for schizophrenia
by: Subramanian, Selvizhi, et al.
Published: (2017)

Alteration of serum biochemical parameters and urinalysis in Sprague Dawley rats administered with N-methyl-N-nitrosourea
by: Hakimi, M. K., et al.
Published: (2012)

Longitudinal cognitive decline in the AIBL cohort: The role of APOE e4 status
by: Albrecht, Matthew, et al.
Published: (2015)

Longitudinal cognitive decline in the AIBL cohort: the role of APOE ε4 status
by: Foster, J., et al.
Published: (2014)

Disrupted-in-Schizophrenia-1 (DISC1) gene as genetic markers of schizophrenia susceptibility
by: Talib, Norlelawati A., et al.
Published: (2014)

Serum progesterone level in predicting ectopic pregnancy.
by: Shahril AZ,, et al.
Published: (2013)

Motherhood and Schizophrenia: A Critical Review
by: Murray, Polly
Published: (2009)

Study on the performance of the soil stabilisation of peat soil using hydrated lime / Mustan Apo
by: Apo, Mustan
Published: (2006)

Characterisation of low density lipoprotein subfraction profile and apoe genotype among diabetic patients
by: Bebakar, Wan Mohamad Wan
Published: (2001)

Alzheimer's disease detection combining novel radiogenomics of APOE e, structural and functional MRI
by: Suppiah, Subapriya, et al.
Published: (2024)

Offenders with Schizophrenia: Relationship to Psychopathology
by: Huri, Surina Zaman, et al.
Published: (2013)

Abnormal visuomotor processing in schizophrenia
by: Robson, Siân E., et al.
Published: (2015)

Global mental health and schizophrenia
by: Asher, Laura, et al.
Published: (2018)

Probability and magnitude evaluation in schizophrenia
by: Albrecht, Matthew, et al.
Published: (2016)

APOE e4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals: A cross-sectional observational study
by: Cysique, L., et al.
Published: (2015)